Clinician Scientiest/ Research Fellow
University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Germany
Dr. Lisa Leypoldt, MD, is a clinician and researcher specializing in hematology/oncology and internal medicine at the Department of Oncology, Hematology and Bone Marrow Transplantation with Department of Pneumology, University Medical Center Hamburg-Eppendorf in Hamburg, Germany, as well as a postdoctoral research fellow at Dana Farber Cancer Institute, Harvard Medical School in Boston, MA, USA.
Dr. Leypoldt received her medical degree from University of Hamburg after having trained in Hamburg, Münster, and Salt Lake City, UT, USA. Her research, as well as her clinical work, focuses in particular on multiple myeloma and related plasma cell dyscrasias. She is co-principal investigator in academic investigator-initiated clinical trials including the GMMG-CONCEPT trial for high-risk myeloma. Currently, she works in the Medical Oncology laboratory of Constantine Mitsiades at Dana Farber Cancer Institute as a recipient of the Mildred-Scheel-Postdoctoral Scholarship by German Cancer Aid, where she researches on elucidating mechanisms of resistance of multiple myeloma. Dr. Leypoldt has published research articles in scientific journals and was awarded the Young Investigator Award of the International Myeloma Society in 2023.